š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The primary objective of the study is to establish Bioequivalence (BE) of 2...
Status
Completed
Location
1
Start Date
2014-02
Trial ID
NCT02070796
Treatments Being Tested
This study was intended to demonstrate bioequivalence of the Amarin's Rotig...
Status
Completed
Location
Cliantha Research Ltd.
Start Date
2025-12-04
Trial ID
NCT07769359
Treatments Being Tested
This is a Phase 1, open-label, parallel-group study to evaluate rotigotine ...
Status
Completed
Location
MD Clinical
Start Date
2018-05-15
Trial ID
NCT03589066
Treatments Being Tested
The primary objective of this study is to investigate efficacy and safety o...
Status
Completed
Location
Multiple Locations
Start Date
2008-06
Trial ID
NCT00666965
Treatments Being Tested
The objective of this study is to evaluate the adhesion of the test product...
Status
Terminated
Location
Sandoz Investigative Site
Start Date
2019-12-03
Trial ID
NCT04183634
Treatments Being Tested
This study is to investigate the safety and efficacy of Rotigotine add-on t...
Status
Completed
Location
402
Start Date
2012-10
Trial ID
NCT01723904
Treatments Being Tested
Evaluate the benefits of Kinesia-360ā¢ wearable technology in addition to st...
Status
Completed
Location
Pd0049 105
Start Date
2017-03-16
Trial ID
NCT03103919
Treatments Being Tested
The purpose of this trial is to assess whether rotigotine has an effect on ...
Status
Completed
Location
Farmovs-Parexel (Pty) Ltd
Start Date
2006-01
Trial ID
NCT00292227
Treatments Being Tested
The primary objective of this study is to investigate safety of SPM 962 in ...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT01631812
Treatments Being Tested
Phase 1, single center study to assess pharmacokinetic profiles of rotigoti...
Status
Completed
Location
Pharmaron CPC, Inc.
Start Date
2018-11-09
Trial ID
NCT03733561
Treatments Being Tested